Theravance Biopharma, Inc. - Ordinary Shares (TBPH): Price and Financial Metrics

TBPH POWR Grades

• Growth is the dimension where TBPH ranks best; there it ranks ahead of 70.29% of US stocks.
• The strongest trend for TBPH is in Momentum, which has been heading down over the past 47 weeks.
• TBPH's current lowest rank is in the Momentum metric (where it is better than 9.67% of US stocks).

TBPH Stock Summary

• Theravance Biopharma Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than just 4.9% of US listed stocks.
• Equity multiplier, or assets relative to shareholders' equity, comes in at -1.44 for Theravance Biopharma Inc; that's greater than it is for just 4.38% of US stocks.
• As for revenue growth, note that TBPH's revenue has grown -16.46% over the past 12 months; that beats the revenue growth of merely 13.77% of US companies in our set.
• Stocks that are quantitatively similar to TBPH, based on their financial statements, market capitalization, and price volatility, are EVGN, BBIO, OTIC, APTX, and AGIO.
• Visit TBPH's SEC page to see the company's official filings. To visit the company's web site, go to www.theravance.com.

TBPH Valuation Summary

• TBPH's price/sales ratio is 9.5; this is 150% higher than that of the median Healthcare stock.
• Over the past 89 months, TBPH's price/sales ratio has gone down 3267.9.
• TBPH's EV/EBIT ratio has moved down 0 over the prior 89 months.

Below are key valuation metrics over time for TBPH.

TBPH Growth Metrics

• Its 2 year net cashflow from operations growth rate is now at -109.59%.
• Its 3 year revenue growth rate is now at 42.99%.
• Its 2 year net income to common stockholders growth rate is now at 13.41%.

Over the past 33 months, TBPH's revenue has gone up $15,010,000.

The table below shows TBPH's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	64.158	-261.934	-264.161
2021-03-31	66.252	-265.167	-274.643
2020-12-31	71.857	-250.403	-278.017
2020-09-30	82.626	-249.83	-285.189
2020-06-30	76.796	-217.421	-269.977
2020-03-31	87.938	-212.105	-246.928

TBPH's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• TBPH has a Quality Grade of C, ranking ahead of 25% of graded US stocks.
• TBPH's asset turnover comes in at 0.144 -- ranking 229th of 677 Pharmaceutical Products stocks.
• AVTX, SUPN, and NBIX are the stocks whose asset turnover ratios are most correlated with TBPH.

The table below shows TBPH's key quality metrics over time.